Your browser doesn't support javascript.
loading
IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.
Singh, Shubhra; Xiao, Zhilan; Bavisi, Karishma; Roszik, Jason; Melendez, Brenda D; Wang, Zhiqiang; Cantwell, Mark J; Davis, Richard E; Lizee, Greg; Hwu, Patrick; Neelapu, Sattva S; Overwijk, Willem W; Singh, Manisha.
Afiliação
  • Singh S; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Xiao Z; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Bavisi K; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Melendez BD; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Wang Z; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Cantwell MJ; Memgen, Inc., Houston, TX 77046; and.
  • Davis RE; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Lizee G; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Neelapu SS; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
  • Overwijk WW; Nektar Therapeutics, San Francisco, CA 94158.
  • Singh M; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77054; msingh4@mdanderson.org.
J Immunol ; 206(8): 1966-1975, 2021 04 15.
Article em En | MEDLINE | ID: mdl-33722878
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Resistencia a Medicamentos Antineoplásicos / Interleucina-1alfa / Inibidores de Checkpoint Imunológico / Imunoterapia Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Resistencia a Medicamentos Antineoplásicos / Interleucina-1alfa / Inibidores de Checkpoint Imunológico / Imunoterapia Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article